Panel Discussion – Biologics and Biosimilars: Challenges and opportunities in FDD
The last panel discussion of FDD Conclave 2021 was on ‘Biologics and Biosimilars: Challenges and opportunities in FDD’. In this…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
FDD Conclave
Panel Discussion: Oral solid dosage forms: Trends and opportunities
On the second day too, the panel discussion on the trends and opportunities regarding the oral solid dosage forms saw Dr Vinod…
Green formulation development: Strategies and challenges
There is a growing need for sustainable drug discovery and development methods across the global pharma industry and experts feel…
Clean label coatings
Speaking about the clean label coatings, Sanjay Negi, GM, Ideal Cures, said that the company offers clean label products to…
Special Address: S.M.A.R.T Pharmaceuticals
Dr Ajaz Hussain gave a very interesting presentation as part of his Special Address at FDD Conclave 2021 on how and why S.M.A.R.T…
Panel Discussion : Optimising FR&D to expedite regulatory compliance
The moderator of this panel discussion Dr Vinod Arora, Principal Advisor, Institute of Good Manufacturing Practices India (IGMPI),…
Automation and AI for Formulations Development
Dr Ranjit Barshikar, CEO-QbD International; United Nations Adviser - Geneva, gave an insightful presentation about the role of…
Panel Discussion: The pandemic effect on FDD
The first panel discussion at FDD Conclave 2021 witnessed FR&D leaders and experts reflect and discuss on the experiences and…
Application of Quality by Design in development of NovaPure closures
Sharing his views with the audience, Prabhaharan Sankaran, Technical Account Specialist, West Pharmaceutical Services, India,…
Documented Solutions – How customers benefit from Ideal Cures
Suresh Pareek, MD, Ideal Cures spoke on Documented Solutions - How customers benefit from Ideal
Cures at FDD Concave 2021. His…